刺激性肠综合征是患有炎症性肠病患者发展阿片类药物使用障碍的独立危险因素
Yuhan Fu1, Michael Kurin2, Marc Landsman2
1Department of Internal Medicine, Metrohealth Medical Center/Case Western Reserve University, Cleveland, OH 44109, USA.
Journal of personalized medicine
|June 28, 2023
概括
刺激性肠综合征 (IBS) 增加了阿片类药物处方和成的风险在炎症性肠病 (IBD) 患者. 这一发现强调了在IBD护理中需要谨慎的疼痛管理策略.
科学领域:
- 胃肠病学 胃肠病学
- 疼痛管理 疼痛管理
- 成 药物 药物 药物 药物
背景情况:
- 炎症性肠病 (IBD) 患者面临阿片类药物成的风险增加.
- 刺激性肠综合征 (IBS) 的症状甚至可以在IBD缓解期间持续存在.
研究的目的:
- 调查IBS是否是IBD患者阿片类药物成的独立风险因素.
- 在接受阿片类药物治疗的IBD患者中分析IBS和胃肠道症状之间的关联.
主要方法:
- 使用TrinetX数据库进行回顾性队列研究.
- 对于阿片类药物处方和成发展,IBD患者与没有IBS患者的比较.
- 针对胃肠道症状和死亡率的阿片类药物处方患者的子组分析.
主要成果:
- 患有IBD和IBS的患者更有可能接受口服阿片类药物 (CD:24.6%对17.2%;UC:20.2%对12.3%).
- 同时使用IBS显著增加了发展阿片类药物依赖或滥用的风险 (p <0.05).
- 处方阿片类药物的患者出现了更高的GERD,大肠,便秘,恶心和吐率 (p <0.05).
结论:
- 刺激性肠综合征是炎症性肠病患者阿片类药物开始和成的独立风险因素.
- 这些发现强调了在IBD疼痛管理和成风险评估中考虑IBS的重要性.
相关概念视频
Irritable Bowel Syndrome I: Introduction
325
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
325
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
249
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
249
Drugs for Treatment of Diarrhea-Predominant IBS
218
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
218
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
199
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
199
Inflammatory Bowel Disease I: Ulcerative Colitis
226
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
226
Chronic Bowel Disorders: Introduction
490
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
490


